Header Logo

Connection

Carl Maki to Cadherins

Back to Details
This is a "connection" page, showing publications Carl Maki has written about Cadherins.
Carl Maki
Connection Strength
0.215
Cadherins
  1. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15. Cancer Biol Ther. 2022 12 31; 23(1):65-75.
    View in: PubMed
    Score: 0.215
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.